Responses
Liver symposium: impact of clinical research in hepatology
OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive)
Compose a Response to This Article
Other responses
No responses have been published for this article.